# Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine

> **NCT00000635** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 25 (—)

## Conditions studied

- Herpes Simplex
- HIV Infections

## Interventions

- **DRUG:** Trifluridine
- **DRUG:** Bacitracin zinc/Polymyxin B sulfate

## Key facts

- **NCT ID:** NCT00000635
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1992-04
- **Target enrollment:** 25 (—)
- **Last updated:** 2021-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000635, "Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00000635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*